Effect of the antimalarial drug halofantrine in the long QT syndrome due to a mutation of the cardiac sodium channel gene SCN5A

American Journal of Cardiology

Volumn 87, Issue 7, 2001, Pages 909-911

  Piippo, Kirsi ^a   Holmström, Sam ^a   Swan, Heikki ^a   Viitasalo, Matti ^a   Raatikka, Marja ^b   Toivonen, Lauri ^a   Kontula, Kimmo ^a,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; CLARITHROMYCIN; DISOPYRAMIDE; HALOFANTRINE; ISOLEUCINE; MEFLOQUINE; OXATOMIDE; PROCAINAMIDE; QUINIDINE; SODIUM CHANNEL; SULFAMETHOXAZOLE; VALINE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; ATRIOVENTRICULAR BLOCK; AUTOSOMAL DISORDER; CODON; CONTROLLED STUDY; EXON; FEMALE; GENE CLUSTER; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HUMAN; LONG QT SYNDROME; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; QT INTERVAL; SEQUENCE HOMOLOGY; SYNCOPE; TORSADE DES POINTES;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTIMALARIALS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; PHENANTHRENES; SODIUM CHANNELS; TACHYCARDIA, VENTRICULAR;

EID: 0035313448     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01538-1     Document Type: Article

References (18)

1. The molecular genetics of the long QT syndrome: Genes causing fainting and sudden death
2. Spectrum of mutations in long-QT syndrome genes KVLQT1, HERG, SCN5A, KCNE1, and KCNE2
3. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
4. Molecular genetics of the long QT syndrome: Two novel mutations of the KVLQT1 gene and phenotypic expression of the mutant gene in a large kindred
5. Survey of the coding region of the HERG gene in long QT syndrome reveals six novel mutations and an amino acid polymorphism with possible phenotypic effects
6. Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: Identification of an apparent founder mutation in the Finns
7. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel
8. Provocation of ventricular tachycardia by antimalarial drug halofantrine in congenital long QT syndrome
9. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
10. Cardiac conduction defects associate with mutations in SCN5A
11. + channel mutation causing both long-QT and Brugada syndromes
12. Activation and inactivation of the voltage-gated sodium channel: Role of segment S5 revealed by a novel hyperkalemic periodic paralysis mutation
13. Clinical pharmacokinetics of halofantrine
14. Mechanism of cardiotoxicity of halofantrine
15. KVLQT1 C-terminal missense mutation causes a forme fruste long QT syndrome
16. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias
17. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia
18. A common polymorphism associated with antibiotic-induced cardiac arrhythmia